Will Pharmaceuticals Controlling Shareholder Wu Renrong Pledges 690,000 Shares; Cumulative Pledge Ratio Nearly 50%

MaticHoleFiller · 2026-03-24T08:49:43+00:00

Nanjing Weir Pharmaceuticals' controlling shareholder Wu Renrong announced on March 18, 2026 a pledge of 690,000 shares, representing a pledge ratio of 0.51%, to meet personal funding needs. After the pledge, Wu Renrong's cumulative pledged shares reached 9.26 million shares, approaching the warning threshold. Overall controlling shareholder pledge information shows total shareholding of 41% with pledges accounting for approximately 42.87%. The company will continue to monitor the pledge situation and conduct information disclosure.

MaticHoleFiller

2026-03-24 08:49:43

Abstract generation in progress

Nanjing Weier Pharmaceutical Group Co., Ltd. (Stock Code: 603351, Stock Abbreviation: Weier Pharma) announced on March 18, 2026, that the company’s controlling shareholder, Mr. Wu Renrong, has pledged some of his shares in the company.

Details of this share pledge

The announcement shows that controlling shareholder Wu Renrong has pledged 690,000 shares, accounting for 3.73% of his personal holdings and 0.51% of the total share capital of the company. This pledge involves non-restricted shares and is not a supplementary pledge. The pledge started on March 16, 2026, and will expire on March 16, 2027. The pledgee is Nanjing Securities Co., Ltd., and the funds from the pledge are used to meet Mr. Wu Renrong’s personal financial needs.

Shareholder Name
Is controlling shareholder
Number of pledged shares / ten thousand shares
Are shares restricted
Is it a supplementary pledge
Pledge start date
Pledge end date
Pledgee
Percentage of shares held by the shareholder
Percentage of total share capital
Purpose of pledged funds
—
Wu Renrong
Yes
69
No
No
2026-03-16
2027-03-16
Nanjing Securities Co., Ltd.
3.73%
0.51%
Personal financial needs

Cumulative pledge of shareholder shares

As of the disclosure date, the controlling shareholder and its concerted actors have pledged a total of:

Shareholder Name
Shares held
Shareholding ratio
Pledged shares before this disclosure
Pledged shares after this disclosure
Shareholding ratio of pledged shares
Shareholding ratio of total share capital
Pledged shares status
Unpledged shares status
—
Wu Renrong
18,521,981
13.68%
8,570,000
9,260,000
49.99%
6.84%
0
0
0
0
Gao Zengsong
14,111,986
10.42%
6,350,000
6,350,000
45.00%
4.69%
0
0
0
0
Chen Xinguo
14,111,986
10.42%
4,500,000
4,500,000
31.89%
3.32%
0
0
0
0
Shuntai Zonghua
8,788,699
6.49%
3,700,000
3,700,000
42.10%
2.73%
0
0
0
0
Total
55,534,652
41.00%
23,120,000
23,810,000
42.87%
17.58%
0
0
0
0

Note: The total percentage in the above table may have minor discrepancies due to rounding.

From the cumulative pledge data, after this pledge, Mr. Wu Renrong’s total pledged shares reach 9.26 million, accounting for 49.99% of his personal holdings, approaching the 50% pledge warning line. The company’s controlling shareholder and its concerted actors hold a total of 55.53 million shares, representing 41.00% of the total share capital, with a total pledged amount of 23.81 million shares, accounting for 42.87% of their combined holdings and 17.58% of the total share capital.

The announcement also states that none of the pledged shares are restricted or frozen, and there are no restricted or frozen shares among the unpledged shares. The company’s board of directors will continue to monitor the pledge situation and fulfill disclosure obligations in accordance with relevant regulations.

Click to view the original announcement >>

Disclaimer: The market carries risks; investment should be cautious. This article is automatically published by an AI large model based on third-party databases and does not represent Sina Finance’s views. All information in this article is for reference only and does not constitute personal investment advice. Please refer to the actual announcement for accuracy. If you have any questions, contact biz@staff.sina.com.cn.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.